SYNCOM FORMULATIONS (INDIA)
Back to Balance Sheet
|
SYNCOM FORMULATIONS (INDIA) Last 5 Year Deferred Tax Assets / Liabilities History
[Consolidated]
| Mar2025 | Mar2024 | Mar2023 | Mar2022 | Mar2017 | |
|---|---|---|---|---|---|
| Deferred Tax Assets / Liabilities | ₹6.31 Cr | ₹4.98 Cr | ₹4.42 Cr | ₹4.58 Cr | ₹7.16 Cr |
What is the latest Deferred Tax Assets / Liabilities ratio of SYNCOM FORMULATIONS (INDIA) ?
| Year | Deferred Tax Assets / Liabilities |
|---|---|
| Mar2025 | ₹6.31 Cr |
| Mar2024 | ₹4.98 Cr |
| Mar2023 | ₹4.42 Cr |
| Mar2022 | ₹4.58 Cr |
| Mar2017 | ₹7.16 Cr |
How is Deferred Tax Assets / Liabilities of SYNCOM FORMULATIONS (INDIA) Trending?
| Years | Deferred Tax Assets / Liabilities | % Change | |
|---|---|---|---|
| Mar2025 | ₹6.31 Cr | 26.80 | |
| Mar2024 | ₹4.98 Cr | 12.55 | |
| Mar2023 | ₹4.42 Cr | -3.34 | |
| Mar2022 | ₹4.58 Cr | -36.07 | |
| Mar2017 | ₹7.16 Cr | - | |
Compare Deferred Tax Assets / Liabilities of peers of SYNCOM FORMULATIONS (INDIA)
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| SYNCOM FORMULATIONS (INDIA) | ₹1,219.2 Cr | -1.2% | -12.6% | -24.7% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹400,497.0 Cr | -3.5% | -6.4% | -2.6% | Stock Analytics | |
| DIVIS LABORATORIES | ₹165,492.0 Cr | -5.8% | -1.6% | 10.9% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹136,013.0 Cr | 1.4% | 7% | 23.7% | Stock Analytics | |
| CIPLA | ₹112,922.0 Cr | -4.7% | -6.8% | -0.3% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹98,115.0 Cr | -2.8% | -8.1% | -11.1% | Stock Analytics | |
SYNCOM FORMULATIONS (INDIA) Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| SYNCOM FORMULATIONS (INDIA) | -1.2% |
-12.6% |
-24.7% |
| SENSEX | -0.7% |
-1.9% |
8% |
You may also like the below Video Courses